Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2007-08-21
2007-08-21
Duffy, Patricia A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S234100, C530S825000
Reexamination Certificate
active
10150814
ABSTRACT:
In this application is described a composition, Invaplex, derived from a gram negative bacteria for use in generating an immune response in a subject against one or more heterologous species or strains of gram-negative bacteria.
REFERENCES:
patent: 6245892 (2001-06-01), Oaks
patent: 6248329 (2001-06-01), Chandrashekar et al.
patent: 6277379 (2001-08-01), Oaks et al.
patent: WO 00/18354 (2000-04-01), None
Turbyfill et al., Infection and Immunity vol. 68, No. 13, pp. 6624-6632, Dec. 2000.
Alexander et al (Vaccine , 14(11):1053-1061, 1996).
Ellis, R.W. (Chapter 29 in “VACCINES” Plotin, S.A. et al eds, W. B Saunders Co., Philadelphia, PA, 1988, p. 571, second full paragraph.
Jennison et al, FEMS Microbiological Reviews, 28:43-58, 2004.
Charkrabarti et al (Acta Paediatr, 88:161-5, 1999).
Turbyfill et al. (1998) Identification of Epitope and Surface-Exposed Domains ofShigella flexneriInvasion Plasmid Antigen D (IpaD).Infection and Immunity66, 1999-2006.
Barzu et al. (1996) Induction of a Local Anti-IpaC Antibody Response in Mice by Use of aShegella flexneri2a Vaccine Candidate: Implications for Use of IpaC as a Protein Carrier.Infection and Immunity64, 1190-1196.
Turbyfill et al, “Isolation and Characterization of theShigellaInvasin Complex and Use as a New Subunit Vaccine,” Abstracts of the General Meeting of the American Society for Microbiology, vol. 99, May 30, 1999, p. 291.
Oaks et al, “Evaluation of theShigellaInvasin Complex and Purified IpaC as Mucosal Adjuvants,” Abstracts of the General Meeting of the American Society for Microbiology, vol. 99, 1999, p. 282.
Oaks Edwin V.
Turbyfill Kevin R.
Arwine Elizabeth
Duffy Patricia A.
United States of America as represented by the Secretary of the
LandOfFree
Heterologous protection induced by immunization with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterologous protection induced by immunization with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterologous protection induced by immunization with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3890616